Select Publications


Kavallaris M, 2012, Cytoskeleton and human disease,

Book Chapters

McCarroll JA; Sharbeen G; Kavallaris M; Phillips PA, 2019, 'The use of star polymer nanoparticles for the delivery of siRNA to mouse orthotopic pancreatic tumor models', in RNA interference and cancer therapy : methods and protocols, United States, pp. 329 - 353,

Mansfeld FM; Davis TP; Kavallaris M, 2017, 'Nanotechnology in Medical Research', in Skwarczynski M; Toth I (ed.), Micro- and Nanotechnology in Vaccine Development, William Andrew Elsevier, Oxford, UK, pp. 21 - 45,

Kavallaris M; Pasquier E; Andre N, 2014, 'Metronomic Chemotherapy regimens using microtubule-targeting agents:mechanisms of action, pre-clinical activity and future developments.', in Bocci G; Francia G (ed.), Metronomic Chemotherapy, Springer, pp. 69 - 90,

Vittorio O; Kavallaris , 2013, 'Polyphenol Conjugate: Synthesis and Potential Biomedical Applications', in Recent Advances in Drug Delivery Research, Nova Science Publishers, USA

Erlich RB; Kavallaris M; McCarroll J; Phillips P, 2013, 'Nanotechnology, tumour biomarkers and RNA interference for personalized medicine applications', in Shiddiky MJA; Wee EJH; Rauf S; Trau M (ed.), Microfluidics, Nanotechnology and Disease Biomarkers for Personalized Medicine Applications, Nova Science Publishers, pp. 167 - 187,

McCarroll JA; Kavallaris M, 2012, 'Microtubules, drug resistance, and tumorigenesis', in Cytoskeleton and Human Disease, pp. 223 - 240,

Haber M; Kavallaris M, 2000, 'Multidrug Resistance Genes in Neuroblastoma', in Neuroblastoma, edn. Original, Elsevier Science BV, Amsterdam, pp. 207 - 215

Journal articles

Yeola A; Subramanian S; Oliver RA; Lucas CA; Thoms JAI; Yan F; Olivier J; Chacon D; Tursky ML; Srivastava P; Potas JR; Hung T; Power C; Hardy P; Ma DD; Kilian KA; McCarroll J; Kavallaris M; Hesson LB; Beck D; Curtis DJ; Wong JWH; Hardeman EC; Walsh WR; Mobbs R; Chandrakanthan V; Pimanda JE, 2021, 'Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine', Science Advances, vol. 7, pp. eabd1929 - eabd1929,

Utama RH; Atapattu L; O'Mahony AP; Fife CM; Baek J; Allard T; O'Mahony KJ; Ribeiro JCC; Gaus K; Kavallaris M; Gooding JJ, 2020, 'A 3D Bioprinter Specifically Designed for the High-Throughput Production of Matrix-Embedded Multicellular Spheroids', iScience, vol. 23, pp. 101621 - 101621,

Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2020, 'Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion', CANCER RESEARCH, vol. 80, pp. 4129 - 4144,

Salik B; Yi H; Hassan N; Santiappillai N; Vick B; Connerty P; Duly A; Trahair T; Woo AJ; Beck D; Liu T; Spiekermann K; Jeremias I; Wang J; Kavallaris M; Haber M; Norris MD; Liebermann DA; D'Andrea RJ; Murriel C; Wang JY, 2020, 'Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia', Cancer Cell, vol. 38, pp. 263 - 278.e6,

Tjandra KC; Forest CR; Wong CK; Alcantara S; Kelly HG; Ju Y; Stenzel MH; McCarroll JA; Kavallaris M; Caruso F; Kent SJ; Thordarson P, 2020, 'Modulating the Selectivity and Stealth Properties of Ellipsoidal Polymersomes through a Multivalent Peptide Ligand Display', Advanced Healthcare Materials, vol. 9,

Keenan B; Finol-Urdaneta RK; Hope A; Bremner JB; Kavallaris M; Lucena-Agell D; Oliva MA; Diaz JF; Vine KL, 2020, 'N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity', CANCER CELL INTERNATIONAL, vol. 20,

Vittorio O, 2020, 'Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation', Theranostics,

Tjandra KC; McCarthy N; Yang L; Laos AJ; Sharbeen G; Phillips PA; Forgham H; Sagnella SM; Whan RM; Kavallaris M; Thordarson P; McCarroll JA, 2020, 'Identification of Novel Medulloblastoma Cell-Targeting Peptides for Use in Selective Chemotherapy Drug Delivery', Journal of Medicinal Chemistry, vol. 63, pp. 2181 - 2193,

Le Grand M; Kimpton K; Gana CC; Valli E; Valli E; Fletcher JI; Kavallaris M; Kavallaris M, 2020, 'Targeting Functional Activity of AKT Has Efficacy against Aggressive Neuroblastoma', ACS Pharmacology and Translational Science, vol. 3, pp. 148 - 160,

Po’uha ST; Le Grand M; Brandl MB; Gifford AJ; Goodall GJ; Khew-Goodall Y; Kavallaris M, 2020, 'Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration', British Journal of Cancer, vol. 122, pp. 434 - 444,

Somers K; Wen VW; Middlemiss SMC; Osborne B; Forgham H; Jung MS; Karsa M; Clifton M; Bongers A; Gao J; Mayoh C; Raoufi-Rad N; Kusnadi EP; Hannan KM; Scott DA; Kwek A; Liu B; Flemming C; Chudakova DA; Pandher R; Failes TW; Lim J; Angeli A; Osterman AL; Imamura T; Kees UR; Supuran CT; Pearson RB; Hannan RD; Davis TP; McCarroll J; Kavallaris M; Turner N; Gudkov AV; Haber M; Norris MD; Henderson MJ, 2019, 'A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction', Oncogene, vol. 38, pp. 3824 - 3842,

Xie W; Guo Z; Cao Z; Gao Q; Wang D; Boyer C; Kavallaris M; Sun X; Wang X; Zhao L; Gu Z, 2019, 'Manganese-Based Magnetic Layered Double Hydroxide Nanoparticle: A pH-Sensitive and Concurrently Enhanced T1/ T2-Weighted Dual-Mode Magnetic Resonance Imaging Contrast Agent', ACS Biomaterials Science and Engineering, vol. 5, pp. 2555 - 2562,

Moles E; Kavallaris M, 2019, 'A potent targeted cancer nanotherapeutic', Nature Biomedical Engineering, vol. 3, pp. 248 - 250,

Moles E; Kavallaris M; Fernàndez-Busquets X, 2019, 'Modeling the distribution of diprotic basic drugs in liposomal systems: Perspectives on malaria nanotherapy', Frontiers in Pharmacology, vol. 10,

Bayat N; McOrist N; Ariotti N; Lai M; Sia KCS; Li Y; Grace JL; Quinn JF; Whittaker MR; Kavallaris M; Davis TP; Lock RB, 2019, 'Thiol-reactive star polymers functionalized with short ethoxy-containing moieties exhibit enhanced uptake in acute lymphoblastic leukemia cells', International Journal of Nanomedicine, vol. 14, pp. 9795 - 9808,

Cirillo G; Peitzsch C; Vittorio O; Curcio M; Farfalla A; Voli F; Dubrovska A; Iemma F; Kavallaris M; Hampel S, 2019, 'When polymers meet carbon nanostructures: Expanding horizons in cancer therapy', Future Medicinal Chemistry, vol. 11, pp. 2205 - 2231,

Parker SG; Yang Y; Ciampi S; Gupta B; Kimpton K; Mansfeld FM; Kavallaris M; Gaus K; Justin Gooding J, 2018, 'A photoelectrochemical platform for the capture and release of rare single cells', Nature Communications, vol. 9,

Tavallaie R; McCarroll J; Le Grand M; Ariotti N; Schuhmann W; Bakker E; Tilley RD; Hibbert DB; Kavallaris M; Gooding JJ, 2018, 'Nucleic acid hybridization on an electrically reconfigurable network of gold-coated magnetic nanoparticles enables microRNA detection in blood', Nature Nanotechnology, vol. 13, pp. 1066 - 1071,

Faria M; Björnmalm M; Thurecht KJ; Kent SJ; Parton RG; Kavallaris M; Johnston APR; Gooding JJ; Corrie SR; Boyd BJ; Thordarson P; Whittaker AK; Stevens MM; Prestidge CA; Porter CJH; Parak WJ; Davis TP; Crampin EJ; Caruso F, 2018, 'Minimum information reporting in bio–nano experimental literature', Nature Nanotechnology, vol. 13, pp. 777 - 785,

Chang D; Lim M; Goos JACM; Qiao R; Ng YY; Mansfeld FM; Jackson M; Davis TP; Kavallaris M, 2018, 'Biologically targeted magnetic hyperthermia: Potential and limitations', Frontiers in Pharmacology, vol. 9,

Sagnella SM; Trieu J; Brahmbhatt H; MacDiarmid JA; MacMillan A; Whan RM; Fife CM; McCarroll JA; Gifford AJ; Ziegler DS; Kavallaris M, 2018, 'Targeted doxorubicin-loaded bacterially derived nano-cells for the treatment of neuroblastoma', Molecular Cancer Therapeutics, vol. 17, pp. 1012 - 1023,

Oliver S; Yee E; Kavallaris M; Vittorio O; Boyer C, 2018, 'Water Soluble Antioxidant Dextran–Quercetin Conjugate with Potential Anticancer Properties', Macromolecular Bioscience, vol. 18,

Levrier C; Rockstroh A; Gabrielli B; Kavallaris M; Lehman M; Davis RA; Sadowski MC; Nelson CC, 2018, 'Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells', Cell Cycle, vol. 17, pp. 652 - 668,

Parmar A; Pascali G; Voli F; Lerra L; Yee E; Ahmed-Cox A; Kimpton K; Cirillo G; Arthur A; Zahra D; Rahardjo G; Liu GJ; Lengkeek N; Saletta F; Charil A; Kavallaris M; Vittorio O, 2018, 'In vivo [64Cu]CuCl2 PET imaging reveals activity of dextran-Catechin on tumor copper homeostasis', Theranostics, vol. 8, pp. 5645 - 5659,

Parker AL; Teo WS; Pandzic E; Vicente JJ; McCarroll JA; Wordeman L; Kavallaris M, 2018, 'β-Tubulin carboxy-terminal tails exhibit isotype-specific effects on microtubule dynamics in human gene-edited cells', Life Science Alliance, vol. 1,

Oliver S; Jofri A; Thomas DS; Vittorio O; Kavallaris M; Boyer C, 2017, 'Tuneable catechin functionalisation of carbohydrate polymers', Carbohydrate Polymers, vol. 169, pp. 480 - 494,

Parker AL; Teo WS; McCarroll JA; Kavallaris M, 2017, 'An emerging role for tubulin isotypes in modulating cancer biology and chemotherapy resistance', International Journal of Molecular Sciences, vol. 18,

Lovelace MD; Powter EE; Coleman PR; Zhao Y; Parker A; Chang GH; Lay AJ; Hunter J; McGrath AP; Jormakka M; Bertolino P; McCaughan G; Kavallaris M; Vadas MA; Gamble JR, 2017, 'The RhoGAP protein ARHGAP18/SENEX localizes to microtubules and regulates their stability in endothelial cells', Molecular Biology of the Cell, vol. 28, pp. 1066 - 1078,

Wojciechowski JP; Martin AD; Mason AF; Fife CM; Sagnella SM; Kavallaris M; Thordarson P, 2017, 'Choice of Capping Group in Tripeptide Hydrogels Influences Viability in the Three-Dimensional Cell Culture of Tumor Spheroids', ChemPlusChem, vol. 82, pp. 383 - 389,

Kunz-Schughart LA; Dubrovska A; Peitzsch C; Ewe A; Aigner A; Schellenburg S; Muders MH; Hampel S; Cirillo G; Iemma F; Tietze R; Alexiou C; Stephan H; Zarschler K; Vittorio O; Kavallaris M; Parak WJ; Mädler L; Pokhrel S, 2017, 'Nanoparticles for radiooncology: Mission, vision, challenges', Biomaterials, vol. 120, pp. 155 - 184,

Fife CM; Sagnella SM; Teo WS; Po'uha ST; Byrne FL; Yeap YY; Ng DC; Davis TP; McCarroll JA; Kavallaris M, 2017, 'Stathmin mediates neuroblastoma metastasis in a tubulin-independent manner via RhoA/ROCK signaling and enhanced transendothelial migration.', Oncogene, vol. 36, pp. 501 - 511,

Fife CM; McCarroll JA; Kavallaris M, 2017, 'Movers and shakers: cell cytoskeleton in cancer metastasis (vol 171, pg 5507, 2014)', BRITISH JOURNAL OF PHARMACOLOGY, vol. 174, pp. 116 - 116,

Levrier C; Sadowski MC; Rockstroh A; Gabrielli B; Kavallaris M; Lehman M; Davis RA; Nelson CC, 2016, '6α-Acetoxyanopterine: A novel structure class of mitotic inhibitor disrupting microtubule dynamics in prostate cancer cells', Molecular Cancer Therapeutics, vol. 16, pp. 3 - 15,

Parker AL; Turner N; McCarroll JA; Kavallaris M, 2016, 'βIII-Tubulin alters glucose metabolism and stress response signaling to promote cell survival and proliferation in glucose-starved non-small cell lung cancer cells', Carcinogenesis, vol. 37, pp. 787 - 798,

Vittorio O; Cojoc M; Curcio M; Spizzirri UG; Hampel S; Nicoletta FP; Iemma F; Dubrovska A; Kavallaris M; Cirillo G, 2016, 'Polyphenol Conjugates by Immobilized Laccase: The Green Synthesis of Dextran-Catechin', Macromolecular Chemistry and Physics, vol. 217, pp. 1488 - 1492,

Pasquier E; André N; Street J; Chougule A; Rekhi B; Ghosh J; Philip DSJ; Meurer M; MacKenzie KL; Kavallaris M; Banavali SD, 2016, 'Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study', EBioMedicine, vol. 6, pp. 87 - 95,

Ercole F; Mansfeld FM; Kavallaris M; Whittaker MR; Quinn JF; Halls ML; Davis TP, 2016, 'Macromolecular Hydrogen Sulfide Donors Trigger Spatiotemporally Confined Changes in Cell Signaling', Biomacromolecules, vol. 17, pp. 371 - 383,

Byrne FL; McCarroll JA; Kavallaris M, 2016, 'Analyses of tumor burden in vivo and metastasis ex vivo using luciferase-expressing cancer cells in an orthotopic mouse model of neuroblastoma', RNA imaging: methods and protocols, vol. 1372, pp. 61 - 77,

Sharbeen G; McCarroll J; Liu J; Youkhana J; Limbri LF; Biankin AV; Johns A; Kavallaris M; Goldstein D; Phillips PA, 2016, 'Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids', Neoplasia (United States), vol. 18, pp. 753 - 764,

Vittorio O; Brandl M; Cirillo G; Kimpton K; Hinde E; Gaus K; Yee E; Kumar N; Duong H; Fleming C; Haber M; Norris M; Boyer C; Kavallaris M, 2016, 'Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growth', Oncotarget, vol. 7, pp. 47479 - 47493,

Liu PY; Sokolowski N; Guo ST; Siddiqi F; Atmadibrata B; Telfer TJ; Sun Y; Zhang L; Yu D; Mccarroll J; Liu B; Yang RH; Guo XY; Tee AE; Itoh K; Wang J; Kavallaris M; Haber M; Norris MD; Cheung BB; Byrne JA; Ziegler DS; Marshall GM; Dinger ME; Codd R; Zhang XD; Liu T, 2016, 'The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs', Oncotarget, vol. 7, pp. 79217 - 79232,

McCarroll JA; Teo J; Boyer C; Youkhana J; Sagnella S; Duong H; Sharbeen G; Goldstein D; Davis T; Kavallaris M; Phillips P; Liu J, 2016, 'A rationally optimized nanoparticle system for the delivery of RNA interference therapeutics into pancreatic tumors in vivo.', Biomacromolecules, vol. 17, pp. 2337 - 2351,

Back to profile page